Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies

Epidemiology and Infection

Volumn 141, Issue 6, 2013, Pages 1298-1309

  Santak M ^a   Lang Balija, M ^a   Ivancic Jelecki, J ^a   Kosutic Gulija T ^a   Ljubin Sternak, S ^b,c   Forcic, D ^a  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

^b CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Mumps; vaccination (immunization); vaccines

Indexed keywords

MUMPS VACCINE; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; FEMALE; GENOTYPE; GUINEA PIG; MALE; MUMPS; MUMPS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; SEQUENCE ALIGNMENT; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN; WILD TYPE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; EPITOPES; GENOTYPE; GUINEA PIGS; HUMANS; MUMPS; MUMPS VACCINE; MUMPS VIRUS; PHYLOGENY;

EID: 84876945505     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812001896     Document Type: Article

References (36)

1. WHO. Mumps virus nomenclature update: 2012. Weekly Epidemiological Record 2012; 22: 217-224.
2. Watson-Creed G, et al. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. Canadian Medical Association Journal 2006; 175: 483-438.
3. Dayan GH, et al. Recent resurgence of mumps in the United States. New England Journal of Medicine 2008; 358: 1580-1589.
4. Rota JS, et al. Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. Journal of Medical Virology 2009; 81: 1819-1825.
5. Stein-Zamir C, et al. Mumps outbreak in Jerusalem affecting mainly male adolescents. Eurosurveillance 2009; 14: 19440.
6. Carr MJ, et al. Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland. Journal of Clinical Microbiology 2010; 48: 3288-3294.
7. Echevarria JE, et al. Circulation of mumps virus genotypes in Spain from 1996 to 2007. Journal of Clinical Microbiology 2010; 48: 1245-1254.
8. Otto W, et al. Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Eurosurveillance 2010; 15: 19748.
9. Whelan J, et al. Ongoing mumps outbreak in a student populationwith highvaccinationcoverage, Netherlands, 2010. Eurosurveillance 2010; 15: 19554.
10. Walker J, et al. Ongoing outbreak of mumps infection in Oban, Scotland, November 2010 to January 2011. Eurosurveillance 2011; 16: 19803.
11. Peltola H, et al. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clinical Infectious Diseases 2007; 45: 459-466.
12. Gut JP, et al. Symptomatic mumps virus reinfections. Journal of Medical Virology 1995; 45: 17-23.
13. Nojd J, et al. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 2001; 19: 1727-1731.
14. Yoshida N, et al. Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification. Journal of Medical Virology 2008; 80: 517-523.
15. Santak M, et al. Mumps virus strains isolated in Croatia in 1998 and 2005: genotyping and putative antigenic relatedness to vaccine strains. Journal of Medical Virology 2006; 78: 638-643.
16. Ivancic-Jelecki J, Santak M, Forcic D. Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains. Infection, Genetics and Evolution 2008; 8: 603-613.
17. Beck M, et al. Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials. Journal of Biological Standardization 1989; 17: 85-90.
18. Yamanishi K, et al. Studies on live mumps virus vaccine. V. Development of a new mumps vaccine 'AM 9' by plaque cloning. Biken Journal 1973; 16: 161-166.
19. Buynak EB, Hilleman MR. Attenuated mumps virus vaccine 1. Vaccine development. Proceedings of the Society for Experimental Biology and Medicine 1966; 123: 768-775.
20. Mahy BWJ, Kangro HO. Haemagglutination. In: Mahy BWJ, Kangro HO, eds. Virology Methods Manual. London: Academic Press Limited, 1995, 41-43.
21. Forcic D, et al. Comparisons of mumps virus potency estimates obtained by 50% cell culture infective dose assay and plaque assay. Vaccine 2010; 28: 1887-1892.
22. Cross G. Hemagglutination inhibition assay. Seminars in Avian and Exotic Pet Medicine 2002; 11: 15-18.
23. Cohen BJ, et al. Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 2007; 26: 59-66.
24. Perriere G, Gouy M. WWW-Query: an online retrieval system for biological sequence banks. Biochimie 1996; 78: 364-369.
25. Plotkin SA. Correlates of protection induced by vaccination. Clinical and Vaccine Immunology 2010; 17: 1055-1065.
26. Allwinn R, et al. Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity? European Journal of Clinical Microbiology and Infectious Diseases 2011; 30: 1223-1228.
27. Kovamees J, et al. Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Research 1990; 17: 119-129.
28. Orvell C, et al. Characterization of genotype-specific epitopes of the HN protein of mumps virus. Journal of General Virology 1997; 78: 3187-3193.
29. Cusi MG, et al. Localization of a new neutralizing epi-tope on the mumps virus hemagglutinin-neuraminidase protein. Virus Research 2001; 74: 133-137.
30. Rubin S, et al. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine 2006; 24: 2662-2668.
31. Yates PJ, Afzal MA, Minor PD. Antigenic and genetic variation of the HN protein of mumps virus strains. Journal of General Virology 1996; 77: 2491-2497.
32. Kay D, et al. Mumps outbreaks in four universities in the North West of England: prevention, detection and response. Vaccine 2011; 29: 3883-3887.
33. Cantell K. Mumps virus. Advances in Virus Research 1961; 8: 123-164.
34. Flynn M, Mahon BP. Cell mediated and humoral immune response to mumps virus: recent developments. In: Pandalai SG, ed. Recent Research Developments in Virology. Kerala: Transworld Research Network, 2003, pp. 97-115.
35. Date AA, et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. Journal of Infectious Diseases 2008; 197: 1662-1668.
36. Snijders BEP, et al. Mumps vaccine effectiveness in primary schools and households, the Netherlamds, 2008. Vaccine 2012; 30: 2999-3002.